DexCom Inc. is a maker of diabetes monitors. And the Food and Drug Administration approved its STS Continuous Glucose Monitoring System recently. In pre-market activity, shares of DexCom rose $1.79, or 9 percent to $21.60 above the company’s 52-week high of $20.91 from earlier this month. The STS device uses a tiny sensor to monitor the blood sugar level of people with diabetes. To uses it, the device is inserted underneath the skin and connected to a receiver of the size of a cell phone. The device warns of high or low blood sugar levels. The patients can check their levels with just the push of a button.
DexCom’s New Diabetes Monitor Gets OKed by FDA
Posted May 12th 2012 at 11:35 am by admin
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or create a trackback from your own site.
There are no comments yet, be the first to say something
